Inventor · disambiguated record
Bo Chen
Also filed as: CHEN BO · Chen bo-rui
22 granted patents·17 pending applications·43 citations·filing 2005–2025
92Inventor score
Files withKEYMED BIOSCIENCES CO LTD10SHANGHAI JUNSHI BIOSCIENCES INC3BEIJING TIANNUOJIANCHENG PHARMA TECH CO LTD2CHENGDU CONMED BIOSCIENCES CO LTD2KAUVAR LAWRENCE M2
Top patents by PatentIndex Score
39 records- 0187US11306145B2Binding molecules specific for FcγRIIA and uses thereofVIELA BIO INC·Filed 2017·Granted Apr 19, 2022·10 cites·13 claims
- 0286US11725057B2Autoimmune suppressor and application thereofKEYMED BIOSCIENCES CO LTD·Filed 2019·Granted Aug 15, 2023·5 cites·11 claims
- 0386US10066013B2Anti-PD-1 antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES INC·Filed 2014·Granted Sep 4, 2018·12 cites·7 claims
- 0483US9796701B2Kinase inhibitor and use thereofXUANZHU PHARMA CO LTD·Filed 2014·Granted Oct 24, 2017·3 cites·22 claims
- 0581US10815302B2Anti-PD-1 antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES INC·Filed 2018·Granted Oct 27, 2020·2 cites·11 claims
- 0680US12421314B2Binding molecules specific for fcγRIIA and uses thereofHORIZON THERAPEUTICS IRELAND DAC·Filed 2023·Granted Sep 23, 2025·0 cites·10 claims
- 0774US11746153B2Binding molecules specific for FcγRIIA and uses thereofVIELA BIO INC·Filed 2022·Granted Sep 5, 2023·0 cites·9 claims
- 0874US9949976B2Kinase inhibitor and use thereofSIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD·Filed 2017·Granted Apr 24, 2018·1 cites·22 claims
- 0974US9518132B2Protein complexes for antigen binding and methods of useLI ZIJUAN·Filed 2011·Granted Dec 13, 2016·4 cites·16 claims
- 1073US12503514B2Autoimmune suppressor and application thereofKEYMED BIOSCIENCES CO LTD·Filed 2023·Granted Dec 23, 2025·0 cites·15 claims
- 1171US2025032633A1Antibody-drug conjugate and application thereofSHANGHAI MIRACOGEN INC·Filed 2024·Application pending·0 cites
- 1269US2022162294A1Humanized anti-DKK2 antibody and uses thereofUNIV YALE·Filed 2022·Application pending·0 cites
- 1369US2025346685A1Bispecific antibody and use thereofKEYMED BIOSCIENCES CHENGDU CO LTD·Filed 2025·Application pending·0 cites
- 1467US9017668B2High affinity human antibodies to human cytomegalovirus (CMV) gB proteinKAUVAR LAWRENCE M·Filed 2011·Granted Apr 28, 2015·1 cites·10 claims
- 1566US10858447B2Anti-PCSK9 antibody and use thereofJUNSHI BIOSCIENCES CO LTD·Filed 2016·Granted Dec 8, 2020·1 cites·20 claims
- 1665US9828423B2Anti-BLyS antibodyWUHAN THERASOURCE BIOSCIENCES INC·Filed 2013·Granted Nov 28, 2017·3 cites·15 claims
- 1764US2024002540A1Bispecific antibody and use thereofKEYMED BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1863US12301134B2Inverter-based comparatorNCKU RES AND DEVELOPMENT FOUNDATION·Filed 2023·Granted May 13, 2025·0 cites·8 claims
- 1963US2025215097A1Development and use of novel immunomodulatorBEIJING TIANNUOJIANCHENG PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 2062US2021009688A1Anti-pd-1 antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2161US12483114B2Single-inductor multiple-output DC-DC converterUNIV NAT CHENG KUNG·Filed 2023·Granted Nov 25, 2025·0 cites·9 claims
- 2260US11267875B2Humanized anti-DKK2 antibody and uses thereofUNIV YALE·Filed 2016·Granted Mar 8, 2022·0 cites·6 claims
- 2360US8420776B2Ube2g2 binding domain in the ubiquitin ligase gp78 and methods of use thereofWEISSMAN ALLAN·Filed 2005·Granted Apr 16, 2013·1 cites·2 claims
- 2460US2023381336A1Antibody-drug conjugate and application thereofSHANGHAI MIRACOGEN INC·Filed 2021·Application pending·0 cites
- 2556US2023330257A1Development of drug therapeutic agent containing adaptor and use thereofBEIJING TIANNUOJIANCHENG PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 2655US10030069B2High affinity human antibodies to human cytomegalovirus (CMV) gB proteinTRELLIS BIOSCIENCE LLC·Filed 2017·Granted Jul 24, 2018·0 cites·12 claims
- 2754US2024247072A1Development and use of function-enhanced antibody blocking agentKEYMED BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 2854US2024396540A1Inverter-based comparatorUNIV NAT CHENG KUNG·Filed 2024·Application pending·0 cites
- 2954US2025277045A1Development and application of t-cell engager therapeutic agentKEYMED BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3054US2024067751A1Development and application of complement inhibitorKEYMED BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3149US9688744B2High affinity human antibodies to human cytomegalovirus (CMV) GB proteinTRELLIS BIOSCIENCE LLC·Filed 2015·Granted Jun 27, 2017·0 cites·17 claims
- 3249US2022372112A1Tumor therapeutic agent and use thereofKEYMED BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 3348US2024043568A1Development of new tumor engager therapeutic drug and use thereofKEYMED BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3447US2023132604A1Pharmaceutical composition, preparation method therefor and use thereofKEYMED BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 3546US2023029835A1Development and application of therapeutic agents for tslp-related diseasesKEYMED BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 3642US11820820B2Antibody capable of blocking CD47-SIRPa interaction and application thereofCHENGDU CONMED BIOSCIENCES CO LTD·Filed 2019·Granted Nov 21, 2023·0 cites·22 claims
- 3741US12016925B2Carbohydrate composition as pharmaceutical ingredient and use thereofMEDGAEA JAPAN CO LTD·Filed 2022·Granted Jun 25, 2024·0 cites·11 claims
- 3839US10676520B2Antibodies useful in passive influenza immunizationKAUVAR LAWRENCE M·Filed 2011·Granted Jun 9, 2020·0 cites·15 claims
- 3939US2022162331A1Anti-cd73 monoclonal antibody and application thereofCHENGDU CONMED BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bo Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →